City of London Investment Management’s abrdn Life Sciences Investors HQL Stock Holding History

City of London Investment Management’s Portfolio HQL Stock Details HQL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-13,100	Closed	-$231K	–	131
2020 Q3	$231K	Buy	13,100 +2,400	+22%	+$43K	0.02%	125
2020 Q2	$192K	Buy	+10,700	New	+$183K	0.01%	131
2014 Q3	–	Sell	-23,670	Closed	-$492K	–	97
2014 Q2	$492K	Buy	+23,670	New	+$497K	0.04%	65

Other funds holding HQL

NIM

Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AAM

Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return

Matisse Capital Portland, Oregon $250M AUM 26.81% 1-Year Est. Return

FHA

Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return

Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

1CP

1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return

City of London Investment Management's HQL Position: Q4 2020 in Review

City of London Investment Management sold out of abrdn Life Sciences Investors (HQL) in Q4 2020, closing a stake of 13,100 shares — an estimated $231K sold.

City of London Investment Management first reported a position in HQL in Q2 2014 and held it in 3 quarters. The position peaked at $492K in Q2 2014. 66 funds tracked by Wall St. Rank hold HQL as of Q4 2020.

City of London Investment Management reported no remaining abrdn Life Sciences Investors position as of Q4 2020 after selling out during the quarter.
City of London Investment Management sold 13,100 abrdn Life Sciences Investors shares in Q4 2020, an estimated $231K.
City of London Investment Management first reported a position in abrdn Life Sciences Investors in Q2 2014 and held it in 3 quarters.
City of London Investment Management's abrdn Life Sciences Investors position peaked at $492K in Q2 2014.
66 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q4 2020.

Based on City of London Investment Management's 13F filing for Q4 2020, filed 12 Feb 2021.